Literature DB >> 20647165

Modulation of sensorimotor gating in prepulse inhibition by conditional brain glycine transporter 1 deletion in mice.

Philipp Singer1, Detlev Boison, Hanns Möhler, Joram Feldon, Benjamin K Yee.   

Abstract

Inhibition of glycine transporter 1 (GlyT1) augments N-methyl-D-aspartate receptor (NMDAR)-mediated transmission and represents a potential antipsychotic drug target according to the NMDAR hypofunction hypothesis of schizophrenia. Preclinical evaluation of GlyT1 inhibiting drugs using the prepulse inhibition (PPI) test, however, has yielded mixed outcomes. Here, we tested for the first time the impact of two conditional knockouts of GlyT1 on PPI expression. Complete deletion of GlyT1 in the cerebral cortices confers resistance to PPI disruption induced by the NMDAR blocker MK-801 (0.2mg/kg, i.p.) without affecting PPI expression in unchallenged conditions. In contrast, restricting GlyT1 deletion to neurons in forebrain including the striatum significantly attenuated PPI, and the animals remained sensitive to the PPI-disruptive effect of MK-801 at the same dose. These results demonstrate in mice that depending on the regional and/or cell-type specificity, deletion of the GlyT1 gene could yield divergent effects on PPI.
Copyright © 2010 Elsevier B.V. and ECNP. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20647165      PMCID: PMC2980791          DOI: 10.1016/j.euroneuro.2010.06.014

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  87 in total

1.  ACOUSTIC VARIABLES IN THE MODIFICATION OF STARTLE REACTION IN THE RAT.

Authors:  H S HOFFMAN; J L SEARLE
Journal:  J Comp Physiol Psychol       Date:  1965-08

2.  Glycine uptake governs glycine site occupancy at NMDA receptors of excitatory synapses.

Authors:  A J Berger; S Dieudonné; P Ascher
Journal:  J Neurophysiol       Date:  1998-12       Impact factor: 2.714

3.  Modulation of N-methyl-D-aspartate receptor function by glycine transport.

Authors:  R Bergeron; T M Meyer; J T Coyle; R W Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

Review 4.  The acoustic startle response in rats--circuits mediating evocation, inhibition and potentiation.

Authors:  M Koch; H U Schnitzler
Journal:  Behav Brain Res       Date:  1997-12       Impact factor: 3.332

Review 5.  Psychopharmacology of dopamine: the contribution of comparative studies in inbred strains of mice.

Authors:  S Puglisi-Allegra; S Cabib
Journal:  Prog Neurobiol       Date:  1997-04       Impact factor: 11.685

6.  Genetics, haloperidol, and the Fos response in the basal ganglia: a comparison of the C57BL/6J and DBA/2J inbred mouse strains.

Authors:  N Patel; B Hitzemann; R Hitzemann
Journal:  Neuropsychopharmacology       Date:  1998-06       Impact factor: 7.853

7.  Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers.

Authors:  A Breier; A K Malhotra; D A Pinals; N I Weisenfeld; D Pickar
Journal:  Am J Psychiatry       Date:  1997-06       Impact factor: 18.112

8.  A hyperglycinergic rat model for the pathogenesis of schizophrenia: preliminary findings.

Authors:  R Waziri; S Baruah
Journal:  Schizophr Res       Date:  1999-06-22       Impact factor: 4.939

9.  Genetics, haloperidol-induced catalepsy and haloperidol-induced changes in acoustic startle and prepulse inhibition.

Authors:  J McCaughran; E Mahjubi; E Decena; R Hitzemann
Journal:  Psychopharmacology (Berl)       Date:  1997-11       Impact factor: 4.530

10.  Analysis of a gene encoding two glycine transporter variants reveals alternative promoter usage and a novel gene structure.

Authors:  B Borowsky; B J Hoffman
Journal:  J Biol Chem       Date:  1998-10-30       Impact factor: 5.157

View more
  6 in total

Review 1.  A conceptual and practical guide to the behavioural evaluation of animal models of the symptomatology and therapy of schizophrenia.

Authors:  Benjamin K Yee; Philipp Singer
Journal:  Cell Tissue Res       Date:  2013-04-12       Impact factor: 5.249

Review 2.  Modeling resilience to schizophrenia in genetically modified mice: a novel approach to drug discovery.

Authors:  Andra Mihali; Shreya Subramani; Genevieve Kaunitz; Stephen Rayport; Inna Gaisler-Salomon
Journal:  Expert Rev Neurother       Date:  2012-07       Impact factor: 4.618

Review 3.  Glycine transporters as novel therapeutic targets in schizophrenia, alcohol dependence and pain.

Authors:  Robert J Harvey; Benjamin K Yee
Journal:  Nat Rev Drug Discov       Date:  2013-11       Impact factor: 84.694

4.  N-Methyl-D-Aspartate Receptors Involvement in the Gentamicin-Induced Hearing Loss and Pathological Changes of Ribbon Synapse in the Mouse Cochlear Inner Hair Cells.

Authors:  Juan Hong; Yan Chen; Yanping Zhang; Jieying Li; Liujie Ren; Lin Yang; Lusen Shi; Ao Li; Tianyu Zhang; Huawei Li; Peidong Dai
Journal:  Neural Plast       Date:  2018-07-15       Impact factor: 3.599

Review 5.  Glycine Signaling in the Framework of Dopamine-Glutamate Interaction and Postsynaptic Density. Implications for Treatment-Resistant Schizophrenia.

Authors:  Andrea de Bartolomeis; Mirko Manchia; Federica Marmo; Licia Vellucci; Felice Iasevoli; Annarita Barone
Journal:  Front Psychiatry       Date:  2020-05-14       Impact factor: 4.157

Review 6.  Synergistic Control of Transmitter Turnover at Glycinergic Synapses by GlyT1, GlyT2, and ASC-1.

Authors:  Volker Eulenburg; Swen Hülsmann
Journal:  Int J Mol Sci       Date:  2022-02-25       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.